Cycloguanil is a dihydrofolate reductase inhibitor and an active metabolite of the antimalarial drug proguanil, acting by blocking folate metabolism essential for parasite growth. Belonging to the biguanide… Read more
Cycloguanil is a dihydrofolate reductase inhibitor and an active metabolite of the antimalarial drug proguanil, acting by blocking folate metabolism essential for parasite growth. Belonging to the biguanide class, this compound is primarily utilized in the prophylaxis and treatment of malaria. This collection includes high-quality reference standards of the cycloguanil API, alongside its related pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds such as d4 and d6 forms. These analytical standards are essential for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control testing. By providing consistent materials for chromatographical analysis and mass spectrometry, these compounds assist in the accurate identification and quantification of impurities in complex matrices, ensuring compliance with established regulatory and pharmacopeial standards throughout the drug development lifecycle.